The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model

Prostate

Volumn 73, Issue 5, 2013, Pages 449-454

  Caso, Jorge ^a   Masko, Elizabeth M ^a   Ii, Jean A Thomas ^a   Poulton, Susan H ^a   Dewhirst, Mark ^a   Pizzo, Salvatore V ^a   Freedland, Stephen J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

castration; diet; IGF 1; insulin; low carbohydrate; prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER SURVIVAL; CARBOHYDRATE DIET; CASTRATION; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; KETOGENIC DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANDROGENS; ANIMAL FEED; ANIMALS; CELL LINE, TUMOR; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; ENERGY INTAKE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KETOGENIC DIET; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; ORCHIECTOMY; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875208817     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22586     Document Type: Article

References (30)

1. Baade PD, Youlden DR, Krnjacki LJ,. International epidemiology of prostate cancer: Geographical distribution and secular trends. Mol Nutr Food Res 2009; 53 (2): 171-174.
2. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ,. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994; 86 (4): 281-286.
3. Kolonel LN, Nomura AM, Cooney RV,. Dietary fat and prostate cancer: Current status. J Natl Cancer Inst 1999; 91 (5): 414-428.
4. Walker M, Aronson KJ, King W, Wilson JW, Fan W, Heaton JP, MacNeily A, Nickel JC, Morales A,. Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer 2005; 116 (4): 592-598.
5. Wu K, Hu FB, Willett WC, Giovannucci E,. Dietary patterns and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 2006; 15 (1): 167-171.
6. Kobayashi N, Barnard RJ, Said J, Hong-Gonzalez J, Corman DM, Ku M, Doan NB, Gui D, Elashoff D, Cohen P, Aronson WJ,. Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Cancer Res 2008; 688 (8): 3066-3073.
7. Ngo TH, Barnard RJ, Anton T, Tran C, Elashoff D, Heber D, Freedland SJ, Aronson WJ,. Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Cancer Res 2004; 64 (4): 1252-1254.
8. Ngo TH, Barnard RJ, Cohen P, Freedland S, Tran C, deGregorio F, Elshimali YI, Heber D, Aronson WJ,. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res 2003; 9 (7): 2734-2743.
9. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD,. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995; 87 (19): 1456-1462.
10. Mavropoulos JC, Isaacs WB, Pizzo SV, Freedland SJ,. Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? Urology 2006; 68 (1): 15-18.
11. Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, Pizzo SV, Isaacs WB,. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 2008; 68 (1): 11-19.
12. Mavropoulos JC, Buschemeyer WC III, Tewari AK, Rokhfeld D, Pollak M, Zhao Y, Febbo PG, Cohen P, Hwang D, Devi G, Demark-Wahnefried W, Westman EC, Peterson BL, Pizzo SV, Freedland SJ,. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phila) 2009; 2 (6): 557-565.
13. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA,. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 2003; 56 (3): 201-206.
14. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D,. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer 2007; 58 (1): 35-42.
15. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC,. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 2003; 12 (2): 84-89.
16. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, Maynard M, Gillatt D, Pearce A, Hamdy FC, Neal DE, Holly JM,. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 2003; 88 (11): 1682-1686.
17. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ,. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 2002; 13 (10): 929-935.
18. Powolny AA, Wang S, Carlton PS, Hoot DR, Clinton SK,. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. Mol Carcinog 2008; 47 (6): 458-465.
19. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M,. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 2007; 99 (23): 1793-1800.
20. Masko EM,., Thomas JA II, Antonelli JA, Lloyd JC, Phillips TE, Poulton SH, Dewhirst MW, Pizzo SV, Freedland SJ,. Low-carbohydrate diets and prostate cancer: How low is "low enough "? Cancer Prev Res (Phila) 2010; 3 (9): 1124-1131.
21. Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM,. The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis. J Cancer Surviv 2010; 4 (2): 128-139.
22. Keating NL, O'Malley AJ, Freedland SJ, Smith MR,. Diabetes and cardiovascular disease during androgen deprivation therapy: Observational study of veterans with prostate cancer. J Natl Cancer Inst 2010; 102 (1): 39-46.
23. Freedland SJ, Eastham J, Shore N,. Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer. Prostate Cancer Prostatic Dis 2009; 12 (4): 333-338.
24. Thomas JA II, Antonelli JA, Lloyd JC, Masko EM, Poulton SH, Phillips TE, Pollak M, Freedland SJ,. Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. Prostate Cancer Prostatic Dis 2010; 13 (4): 350-355.
25. Albanes D, Weinstein SJ, Wright ME, Männistö S, Limburg PJ, Snyder K, Virtamo J,. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 2009; 101 (18): 1272-1279.
26. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M,. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998; 279 (5350): 563-566.
27. Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, Montella M, Franceschi S, La Vecchia C,. Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 2005; 16 (1): 152-157.
28. Meckling KA, O'Sullivan C, Saari D,. Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. J Clin Endocrinol Metab 2004; 89 (6): 2717-2723.
29. Lloyd JC, Antonelli JA, Phillips TE, Masko EM, Thomas JA, Poulton SH, Pollak M, Freedland SJ,. Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. J Urol 2010; 183 (4): 1619-1624.
30. http://www.clinicaltrials.gov/ct2/show/NCT00932672?term= prostate+cancer+AND+diet&state1=NA%3AUS%3ANC&rank=2 (accessed on: December 18, 2011).